Literature DB >> 15331882

Accumulation of selected carotenoids, alpha-tocopherol and retinol in human ovarian carcinoma ascitic fluid.

Florian J Schweigert1, Jens Raila, Jalid Sehouli, Ulrich Buscher.   

Abstract

BACKGROUND: Patients with severe forms of cancer are reported to have reduced concentrations of micronutrients in plasma due to the chronic reduction of food intake and an increased metabolism of these components. The purpose of this study was to evaluate if an accumulation of carotenoids, alpha-tocopherol and retinol in malignant ascitic fluid in women with ovarian cancer might contribute to a loss of these components from plasma.
METHODS: Blood and ascitic fluid samples obtained from 21 women with ovarian carcinomas and 17 healthy controls were analyzed for retinol, retinol-binding protein (RBP), alpha-tocopherol and carotenoids.
RESULTS: Plasma concentrations of all micronutrients were lower in cancer patients compared to controls. Ascitic fluid concentration of all investigated components was comparable (73-110%) to plasma. While the mean concentration of retinol in malignant ascites represented 73% of that in plasma, the concentration of RBP was less than 10% resulting in an increased mean molar ratio of retinol to RBP from 1.18 to 10.5.
CONCLUSIONS: The results suggest that lower plasma concentrations of micronutrients in women suffering from ovarian carcinoma are not only caused by a cachexia-induced decrease of food intake and a higher rate of metabolic utilization, but also by a substantial yet not considered transfer from plasma into ascitic fluid possibly associated with plasma lipoproteins. This raises questions with regard to the protective function of these plasma components in ascitic fluid, the consequences of paracentesis on an additional supplementation and finally the possibility to use one or a combination of these components as an additional marker to discriminate between benign and malignant ascites. Copyright (c) 2004 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331882     DOI: 10.1159/000080457

Source DB:  PubMed          Journal:  Ann Nutr Metab        ISSN: 0250-6807            Impact factor:   3.374


  6 in total

1.  Intraperitoneal administration of cisplatin plus bevacizumab for the management of malignant ascites in ovarian epithelial cancer: results of a phase III clinical trial.

Authors:  Hui Zhao; Xiaosong Li; Dianjun Chen; Jianhua Cai; Yan Fu; Huanrong Kang; Jie Gao; Ke Gao; Nan Du
Journal:  Med Oncol       Date:  2015-01-22       Impact factor: 3.064

Review 2.  Complete remission of ovarian cancer induced intractable malignant ascites with intraperitoneal bevacizumab. Immunological observations and a literature review.

Authors:  Filippo Bellati; Chiara Napoletano; Ilary Ruscito; Maria Pastore; Milena Pernice; Morena Antonilli; Marianna Nuti; Pierluigi Benedetti Panici
Journal:  Invest New Drugs       Date:  2009-11-24       Impact factor: 3.850

3.  Urinary vitamin A excretion in very low birth weight infants.

Authors:  Britta Nagl; Andrea Loui; Jens Raila; Ursula Felderhoff-Mueser; Michael Obladen; Florian J Schweigert
Journal:  Pediatr Nephrol       Date:  2008-08-28       Impact factor: 3.714

4.  Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients.

Authors:  Beate Gericke; Jens Raila; Jalid Sehouli; Sophie Haebel; Dominique Könsgen; Alexander Mustea; Florian J Schweigert
Journal:  BMC Cancer       Date:  2005-10-17       Impact factor: 4.430

5.  Evaluation of Matrix Metalloproteinases, Cytokines and Their Potential Role in the Development of Ovarian Cancer.

Authors:  Mahmood Rasool; Arif Malik; Muhammad Abdul Basit Ashraf; Gulshan Parveen; Shazia Iqbal; Irfan Ali; Mahmood Husain Qazi; Muhammad Asif; Kashif Kamran; Asim Iqbal; Saima Iram; Sami Ullah Khan; Mohammad Zahid Mustafa; Ahmad Zaheer; Rozeena Shaikh; Hani Choudhry; Mohammad Sarwar Jamal
Journal:  PLoS One       Date:  2016-11-30       Impact factor: 3.240

6.  Meta-analysis of the association between dietary lycopene intake and ovarian cancer risk in postmenopausal women.

Authors:  Xinli Li; Jiuhong Xu
Journal:  Sci Rep       Date:  2014-05-09       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.